FILTER

Refine your search with the following facets to narrow down your results.

18 Current news of Avecia Biologics

UK consortium led by Paraytec Ltd to develop analytical instrumentation to detect aggregation in biopharmaceutical processing

04-Dec-2007 - A multi-disciplinary UK consortium of partners including Avecia, Intertek ASG, Lonza, Paraytec and the University of Bradford has recently been awarded research grants by the Technology Strategy Board and the Engineering and Physical Sciences Research Council. The part funded £1M+ project is to ...

biopharmaceuticals Lonza medicine

Avecia completes sale of its Electronic Materials businesses

20-Feb-2006 - Avecia announced that it has completed the sale of its Electronic Materials businesses (Ink jet and Electrophotography) to FUJIFILM, having obtained all necessary approvals. This successfully concludes a sale agreement previously announced on 26th December 2005. The disposal includes all Avecia ...

USA

Avecia completes sales of its Pharmaceuticals business unit

07-Dec-2005 - Avecia announced that it has completed the sale of its Pharmaceuticals custom synthesis business to Nicholas Piramal India Limited (NPIL), having obtained all necessary approvals. This successfully concludes a sale agreement previously announced on 27th October 2005. NPIL has paid GBP 9.5 ...

contract synthesis

Avecia sells Pharmaceuticals business unit to Nicholas Piramal India Ltd

31-Oct-2005 - Avecia announced that it has signed a definitive agreement to sell its Pharmaceutical custom synthesis business to Nicholas Piramal India Ltd for GBP 9.5 million. The transaction, which will fund the business' UK pension fund deficit of between GBP 8 - 9 m, is subject to regulatory and other ...

biotechnology chemicals contract synthesis +2

KemFine acquires Avecia Fine Chemicals Limited

21-Sep-2005 - KemFine Limited, Finland and Avecia Group Plc announced that KemFine has acquired Avecia Fine Chemicals Limited based in Grangemouth, Scotland. Financial details were not disclosed. The combined business will create a major new force in the global fine chemical sector, with a leading position in ...

agrochemicals fine chemicals Finland +2

Reaxa - New Catalyst Technologies Company Launched

24-Jun-2005 - Reaxa Limited, the new catalyst technologies company, formally commenced trading following a successful spin-out from Avecia. Reaxa offers new product platforms for "easier, faster and cleaner chemistry" in pharmaceutical and specialty chemical production. Reaxa is a combined venture between the ...

catalysis catalysts chemistry +10

DSM completes acquisition of NeoResins from Avecia

03-Feb-2005 - Royal DSM N.V. completed the acquisition of NeoResins, the coating resins business of Avecia. The intention of this acquisition was announced on 14 December 2004. Necessary approvals have been obtained from the relevant authorities. The acquisition fits perfectly in DSM's strategy and means a ...

coating resins coatings DSM +2

DSM to acquire NeoResins from Avecia - important step in Vision 2005 strategy

15-Dec-2004 - Royal DSM N.V. intends to acquire NeoResins, the coating resins business of Avecia. It is anticipated that the closing will take place in the first quarter of 2005. The acquisition fits perfectly in DSM's strategy and means a substantial strengthening of DSM's coating resins business, part of the ...

coating resins coatings DSM +1

Avecia and Copperhead Chemical Company announce the sale / acquisition of Avecia's Special Drug Mixtures Business

25-Nov-2004 - Avecia Group Plc of Manchester, England and Copperhead Chemical Company of Tamaqua, Pennsylvania jointly announce that Copperhead has acquired Avecia's Special Drug Mixtures (SDM) business. Details of the transaction were not disclosed. The SDM business is centered on a line of standard and ...

angina bases food ingredients +2

Catalyst Technology Wins Again for Avecia Partnership

20-Oct-2004 - Avecia's EnCat(TM) catalyst technology for pharmaceutical and fine chemical production has won its second major industry award of 2004. A collaboration between Cambridge University, Syngenta, AstraZeneca and Avecia, EnCat(TM) has received the Institute of Applied Catalysis (iAc) innovation award ...

AstraZeneca catalysis catalysts +10